Form 10-Q IDERA PHARMACEUTICALS, For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Idera Pharmaceuticals, Inc. (IDRA) Misses Q2 EPS by 1c
August 12, 2014 7:41 AM EDTIdera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q2 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $38 thousand, versus $29 thousand reported last year.
For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.
... More


